Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diartis Pharmaceuticals Inc.

www.diartispharma.com

Latest From Diartis Pharmaceuticals Inc.

Financings Of The Fortnight: Too Soon To Size Up Impact Of The U.S. JOBS Act

Plus news on recent financings by Onyx Therapeutics, InterMune, Versartis and Aileron Therapeutics.

BioPharmaceutical Business Strategies

Recent Financings of Private Companies (03/11)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.

Investing A La Carte: Making Separate Bets on Discovery and Development to Boost Near-Term Returns

As executives and investors scramble to find business models that more closely link investment and return, a handful of technology firms have alit on variations of a capital-efficient strategy: let someone else do the development dirty work.
BioPharmaceutical Strategy

Selected Start-Ups (03/2011)

In Vivo briefly describes these recently founded companies: 2C Tech Corp., Atherolysis Medical, Axena Technologies, Diartis Pharmaceuticals, Prevention Pharmaceuticals and RegeneCure.
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Diartis Pharmaceuticals Inc.
  • Senior Management
  • Jeffrey L Cleland, CEO
    Paul Westberg, SVP, Bus. Dev.
  • Contact Info
  • Diartis Pharmaceuticals Inc.
    Phone: (650) 963-8595
    500 Ellis St.
    Mountain View, CA 94043
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register